The aim of the study was to ascertain the role of I-131 scintigraphy (
RIS) in the follow-up of oxyphilic thyroid carcinomas (OTC). It is dis
cussed that metastases (M) and local recurrencies (LR) are incapable o
f accumulating I-131 sufficiently; therefore, the usual strategy of RI
S cannot be used for follow-up. The re-examination of 91 patients suff
ering from OTC showed that 10/20 patients with M/LR did have a positiv
e uptake of I-131, which could be used for therapy in 8 patients. An a
blation of M using high-dose I-131 therapy could be demonstrated in th
ree younger patients who had cervical lymph node M 3 months after thyr
oidectomy as an early manifestation of their disease. In three patient
s RIS first led to the metastatic site. The clinical course of patient
s with distant M that developed at a later stage was unfavourable, eve
n though they did accumulate I-131. Patients with positive uptake of I
-131 in M/LR were significantly younger (55a) than patients who had no
uptake (67a) and belonged more often to stage I and II of UlCC, namel
y 7/10 vs 2/10. RIS should be used especially in an early interval aft
er thyroidectomy and individually for follow-up: as a diagnostic metho
d and therapeutic instrument.